Novartis AGNVS

Where NVS's P/E ratio sits inside its own 10-year distribution, with the yearly high, low and average.

$159.99-3.10 (-1.90%)Previous close
NYSEHealthcare

NVS P/E ratio: current value, 10-year range and year-by-year history

24.1Historically pricey

NVS's p/e ratio is higher than 82% of the last 10 years.

P/E ratio History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
NVS P/E ratio historyNVS P/E ratio from Sep 2023 to Sep 2026: low 11.28, high 27.3, latest 24.13.1014.6419.2923.9428.58Sep 23Apr 24Nov 24Jun 25Jan 26Sep 26med 17.89

NVS P/E ratio by year

Yearly range of NVS’s p/e ratio from 2016 to 2026. Over the full period it ranged from 6.9 to 30.5, averaging 18.8.

NVS P/E ratio — yearly low, average, high and year-end values
YearLowAverageHighYear-end
202619.322.024.624.1
202516.017.819.719.3
202411.313.716.516.5
202324.027.030.527.1
20226.97.89.08.8
20217.821.926.57.8
202013.221.428.925.4
201913.115.818.317.7
201810.616.324.213.3
201720.924.527.225.0
201619.921.924.521.5

Get notified when NVS P/E ratio crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.

FormulaPrice / Earnings Per Share
Full guide
How to read this chart

The chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.

Key caveats
  • Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
  • A falling P/E trend may signal a business in structural decline, not a buying opportunity.

Is NVS P/E ratio High or Low Right Now?

Novartis AG's P/E ratio is currently 24.1, which is historically pricey relative to its 10-year historical range. The 10-year median P/E ratio for NVS is approximately 18.9. See all NVS valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.